Design Therapeutics Inc
DSGN
NASDAQ
Biotechnology
$14.83
USD
+0.44 (+3.06%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $900.55M
Volume 259.8K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
GERN | Geron Corp | $1.01B | - | +24.4% | - | |
OLMA | Olema Pharmaceuticals Inc | $919.60M | - | - | - | |
KURA | Kura Oncology Inc | $915.26M | - | - | - | |
DSGN | Design Therapeutics Inc | $900.55M | - | - | - | |
CADL | Candel Therapeutics Inc | $864.59M | - | - | - | |
ANNX | Annexon Inc | $856.08M | - | - | - | |
CLYM | Climb Bio Inc | $846.04M | - | - | - | |
AURA | Aura Biosciences Inc | $793.34M | - | - | - | |
FTH | Faeth Therapeutics, Inc | $737.74M | - | - | - |
Top Peer by Growth
Geron Corp
+24.4% YoY Revenue
Best 1-Year Return
Climb Bio Inc
+793.8% Return